Docebo Income Statement (2019-2026) | DCBO

Income Statement Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue (Quarter)
27.07M29.80M32.05M34.94M36.97M38.95M41.46M43.59M46.51M49.28M51.40M53.05M55.43M57.04M57.30M60.73M61.62M63.04M65.62M68.65M
Cost of Revenue (Quarter)
5.68M6.09M6.55M6.98M7.14M7.51M8.05M8.41M8.78M9.26M9.93M10.26M10.46M10.65M11.39M11.58M12.13M12.74M14.35M14.12M
Gross Profit (Quarter)
21.39M23.71M25.50M27.96M29.83M31.45M33.41M35.18M37.73M40.02M41.48M42.80M44.97M46.39M45.90M49.15M49.49M50.30M51.27M54.53M
Operating items
Amortization - Intangibles (Quarter)
0.09M0.08M-0.08M0.17M0.18M0.17M0.18M0.18M0.16M
Research & Development (Quarter)
5.48M5.50M6.19M6.11M6.11M6.38M7.38M8.81M10.27M9.02M10.41M10.77M11.15M11.58M13.40M12.70M11.90M12.11M15.46M12.99M
Selling, General & Administrative (Quarter)
6.82M7.26M7.38M7.60M7.82M7.39M7.56M9.35M8.32M8.57M8.15M8.18M8.38M7.87M8.72M8.39M9.17M8.41M11.34M9.49M
Restructuring Costs (Quarter)
0.10M0.08M0.23M0.99M1.00M1.01M0.47M0.57M0.08M
Other Operating Expenses (Quarter)
7.62M13.79M0.01M17.68M0.20M21.12M0.02M-0.03M19.71M18.11M0.00M25.96M29.48M
Operating Expenses (Quarter)
19.92M26.66M32.37M25.85M20.80M31.52M33.78M42.71M34.62M38.95M37.25M19.94M40.25M38.57M44.19M21.56M21.65M20.60M52.76M51.95M
Operating Income (Quarter)
1.46M-2.95M-6.87M2.11M9.02M-0.07M-0.38M-7.52M3.11M1.08M4.23M4.52M4.72M7.83M1.71M27.59M27.84M29.70M-1.49M2.58M
EBIT (Quarter)
1.46M-2.95M-6.87M2.11M9.02M-0.07M-0.38M-7.52M3.11M1.08M4.23M4.52M4.72M7.83M1.71M27.59M27.84M29.70M-1.49M2.58M
Non-operating items
Other Non Operating Income (Quarter)
-4.76M0.10M3.39M-0.02M-0.02M0.56M0.18M4.36M-0.00M3.02M-0.00M-0.01M0.27M-1.84M-0.00M-0.00M0.10M0.08M-2.27M
Non Operating Income (Quarter)
-0.03M0.04M0.02M0.33M1.32M1.83M2.17M2.41M1.93M2.23M0.55M0.62M0.67M-0.65M0.41M-1.08M
Net income details
EBT (Quarter)
4.03M-1.59M3.75M3.05M10.37M2.55M1.61M-1.47M5.04M3.31M4.77M5.21M5.34M8.39M2.36M4.68M8.25M9.16M-1.90M4.55M
Tax Provisions (Quarter)
0.80M-1.46M0.13M0.36M0.10M0.18M0.36M0.56M1.00M0.09M-0.40M0.51M0.38M-3.52M0.88M1.61M2.14M-17.69M-0.28M-0.76M
Profit After Tax (Quarter)
0.66M-1.43M-6.96M2.10M10.27M1.60M1.25M-5.67M4.05M3.22M5.17M4.70M4.96M11.91M1.47M3.08M6.11M26.85M-1.62M2.26M
Other Income (Quarter)
4.69M0.08M5.16M10.69M-0.70M-0.16M-4.21M3.78M-3.36M0.90M0.45M-0.76M2.80M-1.17M0.09M-0.39M
Income from Continuing Operations (Quarter)
3.23M-0.13M3.62M2.69M10.27M2.37M1.25M-2.02M4.05M3.22M5.17M4.70M4.96M11.91M1.47M3.08M6.11M26.85M-1.62M5.31M
Consolidated Net Income (Quarter)
3.23M-0.13M3.62M2.69M10.27M2.37M1.25M-2.02M4.05M3.22M5.17M4.70M4.96M11.91M1.47M3.08M6.11M26.85M-1.62M5.31M
Income towards Parent Company (Quarter)
3.23M-0.13M3.62M2.69M10.27M2.37M1.25M-2.02M4.05M3.22M5.17M4.70M4.96M11.91M1.47M3.08M6.11M26.85M-1.62M5.31M
Net Income towards Common Stockholders (Quarter)
3.23M-0.46M3.62M2.69M10.27M3.39M1.25M-2.02M4.05M8.30M5.17M7.93M8.26M8.66M1.47M8.91M9.90M13.26M-1.62M5.31M
Additional items
EPS (Basic) (Quarter)
0.10-0.010.110.080.310.100.04-0.060.120.260.170.260.270.290.050.300.340.46-0.060.21
EPS (Diluted) (Quarter)
0.09-0.010.110.080.300.100.04-0.060.120.250.170.260.270.280.050.290.330.45-0.060.20
Shares Outstanding (Quarter)
32.83M32.87M33.02M33.02M33.04M33.07M33.15M33.15M32.47M32.53M30.32M30.35M30.22M30.27M30.26M29.91M29.52M28.69M28.08M25.46M
Shares Outstanding (Diluted) (Quarter)
34.12M32.87M33.02M34.02M34.07M34.04M34.16M33.15M33.51M33.68M31.04M31.06M30.94M30.99M30.93M30.56M30.20M29.37M28.73M26.80M
Shares Outstanding (Entity) (Quarter)
0.33M0.33M0.33M0.33M0.33M0.33M0.33M0.33M0.32M0.33M0.30M0.30M0.30M0.30M0.30M0.30M0.30M0.29M0.28M0.25M
EBITDA (Quarter)
1.46M-1.53M-6.87M2.11M9.02M2.26M-0.38M-7.52M3.11M6.50M4.23M4.52M4.72M7.83M1.71M27.59M27.84M29.70M-1.49M2.58M
Interest Expenses (Quarter)
0.57M0.56M1.02M
Tax Rate (Quarter)
19.73%91.82%3.44%11.76%0.92%7.10%22.57%-38.09%19.77%2.66%-8.30%9.79%7.15%-41.94%37.46%34.32%25.92%-193.19%14.92%-16.73%